Edition:
United Kingdom

Cosmo Pharmaceuticals NV (COPN.S)

COPN.S on Swiss Exchange

111.50CHF
23 May 2018
Change (% chg)

CHF-18.50 (-14.23%)
Prev Close
CHF130.00
Open
CHF112.00
Day's High
CHF112.50
Day's Low
CHF108.50
Volume
130,419
Avg. Vol
23,718
52-wk High
CHF170.10
52-wk Low
CHF108.50

Chart for

About

COSMO Pharmaceuticals SA is a Luxembourg-based pharmaceutical company engaged in the development and production of drugs against selected gastrointestinal diseases. Its clinical research aims to treat Inflammatory Bowel Diseases (IBD), such as ulcerative colitis and Crohn’s disease, as well as colon infections and skin... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): €1,965.91
Shares Outstanding(Mil.): 15.04
Dividend: --
Yield (%): --

Financials

  COPN.S Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): 0.24 -- --
ROI: 5.61 14.84 14.38
ROE: 6.12 16.34 16.07

BRIEF-Cosmo Pharmaceuticals And Pharmascience Establish License And Supply Agreement‍​

* COSMO PHARMACEUTICALS AND PHARMASCIENCE ESTABLISH LICENSE AND SUPPLY AGREEMENT FOR ELEVIEW, METHYLENE BLUE MMX, RIFAMYCIN MMX AND QOLOTAG FOR CANADA​

01 Feb 2018

Earnings vs. Estimates

No consensus analysis data available.